4
Changes in Ownership
Dare Bioscience, Inc. Filed Acc 0001209191-14-027711
Director bought 1,470,582 shares at $7.00 ($10,294,074)
- Director acquired 3,223,956 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
Crane Alan L · Director
Table I: Non-derivative
9 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2014-04-15 | Conversion : show line 1 in the form | +181,399 | 258,600 | I | ||
| 2014-04-15 | Conversion : show line 2 in the form | +355,307 | 613,907 | I | ||
| 2014-04-15 | Conversion : show line 3 in the form | +184,314 | 798,221 | I | ||
| 2014-04-15 | Conversion : show line 4 in the form | +468,263 | 1,266,484 | I | ||
| 2014-04-15 | Conversion : show line 5 in the form | +655,512 | 1,921,996 | I | ||
| 2014-04-15 | Conversion : show line 6 in the form | +592,665 | 2,514,661 | I | ||
| 2014-04-15 | Conversion : show line 7 in the form | +385,435 | 2,900,096 | I | ||
| 2014-04-15 | Conversion : show line 8 in the form | +401,061 | 3,301,157 | I | ||
| 2014-04-15 | Purchase : show line 9 in the form | +1,470,582 | $7.00 | $10,294,074 | 4,771,739 | I |
| Open-market purchases · 1,470,582 sh · avg $7.00 · $10,294,074 | ||||||
Table II: Derivative
10 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2014-04-15 | Conversion : show line 10 in the form Seed Convertible Preferred Stock | −2,500,000 | 0 | I |
| 2014-04-15 | Conversion : show line 11 in the form Series A Convertible Preferred Stock | −3,846,154 | 0 | I |
| 2014-04-15 | Conversion : show line 12 in the form Series B Convertible Preferred Stock | −1,631,107 | 0 | I |
| 2014-04-15 | Conversion : show line 13 in the form Series B-1 Convertible Preferred Stock | −2,513,500 | 0 | I |
| 2014-04-15 | Conversion : show line 14 in the form Series C Convertible Preferred Stock | −9,509,913 | 0 | I |
| 2014-04-15 | Conversion : show line 15 in the form Series D Convertible Preferred Stock | −8,598,139 | 0 | I |
| 2014-04-15 | Conversion : show line 16 in the form 7% Convertible Promissory Notes | −0 | 0 | I |
| 2014-04-15 | Conversion : show line 17 in the form 7% Convertible Promissory Notes | −0 | 0 | I |
| 2014-04-15 | Other disposition : show line 18 in the form Warrant to purchase Series C Preferred | −441,528 | 0 | I |
| 2014-04-15 | Other acquisition : show line 19 in the form Warrant to purchase Common Stock | +30,432 | 30,432 | I |
Loading xslF345X03/doc4.xml…